Successful cryopreservation of mouse and human blastocysts using vitrification solution without sucrose and Ficoll
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q4Scopus Q4
- 저널
- CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY47(6) · pp.847 · 2020
- 피인용
- Web of Science 1Scopus 1
- FWCI (Scopus)
- 0
- JCR IF
- JCR 2019 0.139
- ISSN
- 0390-6663
저자
- Kim, C. W.제1저자Department of Obstetrics and Gynecology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon (Republic of Korea)
- 이동형Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Busan 49241 (Republic of Korea)
- 주보선교신저자Infertility Institute, Pohang Women's Hospital, Pohang 37754 (Republic of Korea)
- 이규섭교신저자Department of Obstetrics and Gynecology, Pusan National University School of Medicine, Busan 49241 (Republic of Korea)
초록
Purpose of Investigation: This study investigated whether cryopreservation of mouse and human blastocysts using vitrification solutions formulated with or without sucrose and Ficoll affects survival rate and pregnancy outcome. Materials and Methods: Two-cell mouse embryos were retrieved from C57BL/CBA females aged 5 weeks and cultured to the blastocyst stage. Artificial shrinkage of blastocysts was performed by blastocoel fluid aspiration before vitrification and then exposed to and vitrified-warmed in one of four different vitrification solutions: 1) 25% glycerol, 25% ethylene glycol, 20% SSS and PBS without sucrose and Ficoll (G25E25), 2) G25E25 with 0.5 M sucrose (G25E25S0.5), 3) G25E25 with 10 mg/mL Ficoll (G25E25F10), and 4) G25E25 with 0.5 M sucrose and 10mg/mL Ficoll (G25E25S0.5F10). Second, in 435 infertile women undergoing in vitro fertilization and embryo transfer (IVF-ET), artificially shrunken blastocysts were vitrified-warmed either in G25E25 (n = 206) and G25E25S0.5F10 (n = 229). Results: In the mouse series, in vitro survival rates of post-warm blastocysts were 93, 91, 90, and 90% in G25E25, G25E25S0.5, G25E25F10, and G25E25S0.5F10, respectively. No significant differences among four groups were found. In the human series, in vitro survival rates and clinical pregnancy rate of blastocysts vitrified-warmed in G25E25 were 96 and 53.3%, respectively, which were similar to those in G25E25S0.5F10 (92 and 51.9%, respectively). Conclusions: Sucrose- and Ficoll-free vitrification solutions can be successfully cryopreserved mouse and human blastocysts without compromising survival rate and pregnancy outcome.
키워드
BlastocystVitrificationSucroseFicollSurvivalPregnancy outcomeLASER-PULSE PRIORARTIFICIAL SHRINKAGEBLASTOCOELE COLLAPSEEMBRYO-TRANSFERCLEAVAGE-STAGESURVIVALCELLS
식별자
- Scopus EID
- 2-s2.0-85099157127
- WoS UID
- 000598997300007



로그인
연구물 목록으로